418 related articles for article (PubMed ID: 25247669)
1. Update on multiple sclerosis treatments.
Bridel C; Lalive PH
Swiss Med Wkly; 2014; 144():w14012. PubMed ID: 25247669
[TBL] [Abstract][Full Text] [Related]
2. New management algorithms in multiple sclerosis.
Sorensen PS
Curr Opin Neurol; 2014 Jun; 27(3):246-59. PubMed ID: 24759080
[TBL] [Abstract][Full Text] [Related]
3. An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
Weinstock-Guttman B
Am J Manag Care; 2013 Nov; 19(17 Suppl):s343-54. PubMed ID: 24494635
[TBL] [Abstract][Full Text] [Related]
4. Oral treatment for multiple sclerosis.
Killestein J; Rudick RA; Polman CH
Lancet Neurol; 2011 Nov; 10(11):1026-34. PubMed ID: 22014437
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
Hutchinson M; Fox RJ; Havrdova E; Kurukulasuriya NC; Sarda SP; Agarwal S; Siddiqui MK; Taneja A; Deniz B
Curr Med Res Opin; 2014 Apr; 30(4):613-27. PubMed ID: 24195574
[TBL] [Abstract][Full Text] [Related]
6. Oral disease-modifying therapies for relapsing-remitting multiple sclerosis.
Thomas RH; Wakefield RA
Am J Health Syst Pharm; 2015 Jan; 72(1):25-38. PubMed ID: 25511835
[TBL] [Abstract][Full Text] [Related]
7. Balancing the benefits and risks of disease-modifying therapy in patients with multiple sclerosis.
Sørensen PS
J Neurol Sci; 2011 Dec; 311 Suppl 1():S29-34. PubMed ID: 22206763
[TBL] [Abstract][Full Text] [Related]
8. Current management of relapsing-remitting multiple sclerosis.
Sedal L; Wilson IB; McDonald EA
Intern Med J; 2014 Oct; 44(10):950-7. PubMed ID: 25302718
[TBL] [Abstract][Full Text] [Related]
9. [Update on current care guidelines: multiple sclerosis].
Duodecim; 2013; 129(5):548-9. PubMed ID: 23520898
[TBL] [Abstract][Full Text] [Related]
10. Severe multiple sclerosis relapse under fingolimod therapy: incident or coincidence?
Castrop F; Kowarik MC; Albrecht H; Krause M; Haslinger B; Zimmer C; Berthele A; Hemmer B
Neurology; 2012 Mar; 78(12):928-30. PubMed ID: 22402856
[No Abstract] [Full Text] [Related]
11. [Emerging therapies for multiple sclerosis].
de Lorenzo-Pinto A; Rodríguez-González CG; Ais-Larisgoitia A
Med Clin (Barc); 2013 Jan; 140(2):76-82. PubMed ID: 22766059
[TBL] [Abstract][Full Text] [Related]
12. ▼Teriflunomide for multiple sclerosis.
Drug Ther Bull; 2014 Jul; 52(7):81-4. PubMed ID: 25012149
[TBL] [Abstract][Full Text] [Related]
13. The future of multiple sclerosis therapy.
Kieseier BC; Wiendl H; Hartung HP; Stüve O
Pharmacol Res; 2009 Oct; 60(4):207-11. PubMed ID: 19717009
[TBL] [Abstract][Full Text] [Related]
14. Multiple sclerosis therapies: molecular mechanisms and future.
Fontoura P; Garren H
Results Probl Cell Differ; 2010; 51():259-85. PubMed ID: 20838962
[TBL] [Abstract][Full Text] [Related]
15. [Current treatment of multiple sclerosis].
Csépány T
Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
[TBL] [Abstract][Full Text] [Related]
16. [Dilemma of further therapeutic step in remitting-relapsing multiple sclerosis in case of ineffectiveness of first-line treatment: fingolimod or natalizumab?].
Gábor L
Ideggyogy Sz; 2014 Mar; 67(3-4):141. PubMed ID: 26118259
[No Abstract] [Full Text] [Related]
17. New oral drugs for multiple sclerosis.
Gasperini C; Ruggieri S
Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371
[TBL] [Abstract][Full Text] [Related]
18. Oral therapy for multiple sclerosis--sea change or incremental step?
Carroll WM
N Engl J Med; 2010 Feb; 362(5):456-8. PubMed ID: 20089958
[No Abstract] [Full Text] [Related]
19. Neurotherapeutics in multiple sclerosis: novel agents and emerging treatment strategies.
DeAngelis T; Lublin F
Mt Sinai J Med; 2008; 75(2):157-67. PubMed ID: 18500719
[TBL] [Abstract][Full Text] [Related]
20. Emerging oral drugs for multiple sclerosis.
Gasperini C; Cefaro LA; Borriello G; Tosto G; Prosperini L; Pozzilli C
Expert Opin Emerg Drugs; 2008 Sep; 13(3):465-77. PubMed ID: 18764723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]